|
Last week, Genome Medicine, BioMed Central's premier medical journal, announced its upcoming January 2009 launch at a special reception held at the American Society of Human Genetics (ASHG), in Philadelphia. In addition to publishing high-quality research, Genome Medicine serves the international research community as a forum for the discussion and critical review of information about all areas of medicine informed by genomic research. |
|
|
|
BioMed Central attends the Open Science Workshop
BioMed Central recently attended a workshop organized by The Open Knowledge Foundation to discuss finding and re-using open scientific resources. The event featured in-depth discussions about open data, the benefits and a "how to do it" section. As an open access publisher, we are heavily involved in promoting data-sharing through our journal BMC Research Notes so this was a valuable forum for the company to share knowledge and opinions with participants from a variety of sectors. |
|
| |
 |
|
|
|
 New from Journal of Biology |
| |
Allan Baker explains the evolutionary significance of studies published in BMC Biology on the speciation of Mexican jays in isolated mountain niches. Meanwhile, Marie-Anne Félix discusses the implications of the capricious susceptibility of different nematode species to RNA interference, as illustrated in a recent paper in BMC Molecular Biology.
If you wish to be notified when new articles are published in Journal of Biology, please sign up for article alerts and/or RSS feeds. |
|
|
 |
|
Honey bee larval proteomics
Genome Biology 2008, 9:R156
Mass spectrometry-based quantitative proteomics was used to quantify nearly 800 proteins during the honey bee larval development.
|
| |
|
|
 |
|
Fenfluramine use and valvulopathy
BMC Medicine 2008, 6:34
In a large cohort of fenfluramine users, almost a fifth of women and over 10% of men have regurgitant valvular heart disease, and the incidence of valvulopathy increases with the duration of fenfluramine use.
|
|
|
|
Clinical review: Balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.
Thomas G Slama
Critical Care 2008, 12:233 (29 October 2008)
|
|
Over 4000 top researchers identifying major advances, including some you may have missed.
|
|
|
|
|
Functional Interaction Trap (FIT)-mediated specific tyrosine phosphorylation of focal adhesion kinase (FAK) in SYF mouse embryonic fibroblasts.
|
|
|
|
|
|
